Last $13.05 USD
Change Today -0.09 / -0.68%
Volume 51.5K
AKAO On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 1:22 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

achaogen inc (AKAO) Snapshot

Open
$13.25
Previous Close
$13.14
Day High
$13.49
Day Low
$12.71
52 Week High
03/24/14 - $19.69
52 Week Low
04/11/14 - $12.14
Market Cap
230.7M
Average Volume 10 Days
104.1K
EPS TTM
--
Shares Outstanding
17.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ACHAOGEN INC (AKAO)

Related News

No related news articles were found.

achaogen inc (AKAO) Related Businessweek News

No Related Businessweek News Found

achaogen inc (AKAO) Details

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant gram-negative infections. The company is principally developing plazomicin, which has completed Phase II clinical trials for the treatment of bacterial infections due to multi-drug resistant Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the research and development of antipseudomonal programs that target infections caused by Pseudomonas aeruginosa. Achaogen, Inc. was incorporated in 2002 and is headquartered in South San Francisco, California.

39 Employees
Last Reported Date: 03/12/14
Founded in 2002

achaogen inc (AKAO) Top Compensated Officers

Chief Executive Officer, President, Chief Med...
Total Annual Compensation: $367.2K
Senior Vice President of Development Operatio...
Total Annual Compensation: $285.6K
Vice President of Finance and Corporate Devel...
Total Annual Compensation: $248.1K
Vice President of Regulatory Affairs
Total Annual Compensation: $279.8K
Compensation as of Fiscal Year 2013.

achaogen inc (AKAO) Key Developments

Achaogen, Inc. Appoints Chris Boerner to Board of Directors

Achaogen, Inc. announced that Dr. Chris Boerner has joined Achaogen's Board of Directors. Dr. Boerner currently serves as Executive Vice President, Commercial for Seattle Genetics, Inc.

Achaogen, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:40 AM

Achaogen, Inc. Presents at 13th Annual Needham Healthcare Conference, Apr-08-2014 10:40 AM. Venue: The Westin Grand Central Hotel, New York, New York, United States. Speakers: Derek A. Bertocci, Chief Financial Officer and Senior Vice President, Kenneth J. Hillan, Chief Executive Officer, President, Chief Medical Officer and Director.

Achaogen, Inc.(NasdaqGM:AKAO) added to NASDAQ Composite Index

Achaogen, Inc. will be added to the NASDAQ Composite Index.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AKAO:US $13.05 USD -0.09

AKAO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AKAO.
View Industry Companies
 

Industry Analysis

AKAO

Industry Average

Valuation AKAO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 26.6x
Price/Book 17.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.6x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACHAOGEN INC, please visit www.achaogen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.